Evidence map›Paper›PMID 33742540›Full record

ArticleAndrology2021

"Mask up to keep it up": Preliminary evidence of the association between erectile dysfunction and COVID-19.

Andrea Sansone, Daniele Mollaioli, Giacomo Ciocca, Elena Colonnello, Erika Limoncin, Giancarlo Balercia, Emmanuele A Jannini

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Andrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05379556 (LOng COvid COmorbidities), which is not on this map. Cited by 55 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 3 pooled it
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05379556 recruitingnot on this mapstarted 2022, after this paper: background citation

LOng COvid COmorbidities: Evaluation of Andrological, Reproductive and Sexual Functions in Patients Recovered From COVID-19

TypeobservationalSponsorFederico II UniversityRan2022 to 2027Enrolled100ConditionsLong Covid-19ArmsAssessment of andrological profile of LO-COCO-ANDRO male patients, Assessment of reproductive function of LO-COCO-ANDRO male patients, Assessment of sexual function of LO-COCO-ANDRO male patients, Assessment of olfactory function of LO-COCO-ANDRO male and female patients
3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 3 syntheses or guidelines pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. The mint versus Covid hypothesis.Medical hypotheses · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Andrea SansoneEndocrinology and Medical Sexology (ENDOSEX, Department of Systems Medicine, University of Rome Tor Vergata, Roma, Italy.ORCID 0000-0002-1210-2843
Daniele MollaioliEndocrinology and Medical Sexology (ENDOSEX, Department of Systems Medicine, University of Rome Tor Vergata, Roma, Italy.ORCID 0000-0001-5947-3310
Giacomo CioccaDepartment of Dynamic and Clinical Psychology, Health Studies "Sapienza" University of Rome, Rome, Italy.ORCID 0000-0002-4256-1776
Elena ColonnelloEndocrinology and Medical Sexology (ENDOSEX, Department of Systems Medicine, University of Rome Tor Vergata, Roma, Italy.ORCID 0000-0002-0081-7163
Erika LimoncinEndocrinology and Medical Sexology (ENDOSEX, Department of Systems Medicine, University of Rome Tor Vergata, Roma, Italy.
Giancarlo BalerciaDivision of Endocrinology, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy.ORCID 0000-0003-1286-1521
Emmanuele A JanniniEndocrinology and Medical Sexology (ENDOSEX, Department of Systems Medicine, University of Rome Tor Vergata, Roma, Italy.ORCID 0000-0002-5874-039X
University of Rome Tor Vergata · ITMarche Polytechnic University · ITSapienza University of Rome · IT

Funding

Italian Ministry of Education, University and Research PRIN 2017S9KTNE_002
6 · The paper itself

Abstract

backgroundErectile dysfunction (ED), as the hallmark of endothelial dysfunction, could be a short- or long-term complication of COVID-19. Additionally, being ED a clinical marker and predictor of non-communicable chronic diseases, particularly cardiovascular, subjects with ED could potentially have a higher risk of contracting COVID-19.

objectivesTo investigate the prevalence of ED among subjects with a reported diagnosis of COVID-19 and to measure the association of COVID-19 and ED. MATERIALS AND

methodsWe reviewed data from the Sex@COVID online survey (performed between April 7 and May 4, 2020, in Italy) to retrieve a sample of Italian male sexually active subjects with reported SARS-CoV-2 infection. A matching sample of COVID-19-negative male sexually active subjects was also retrieved using propensity score matching in a 3:1 ratio. The survey used different standardized psychometric tools to measure effects of lockdown and social distancing on the intrapsychic, relational, and sexual health of Italian subjects.

resultsOne hundred subjects were included in the analysis (25 COVID-positive; 75 COVID-negative). The prevalence of ED, measured with the Sexual Health Inventory for Men, was significantly higher in the COVID+ group (28% vs. 9.33%; p = 0.027). Logistic regression models confirmed a significant effect of COVID-19 on the development of ED, independently of other variables affecting erectile function, such as psychological status, age, and BMI [OR 5.66, 95% CI: 1.50-24.01]. Likewise, subjects with ED were more likely to have COVID-19, once corrected for age and BMI [OR 5.27, 95% CI: 1.49-20.09]. DISCUSSION AND

conclusionOn top of well-described pathophysiological mechanisms, there is preliminary evidence in a real-life population of ED as a risk factor of developing COVID-19 and possibly occurring as a consequence of COVID-19. Universal vaccination against the COVID-19 and the personal protective equipment could possibly have the added benefit of preventing sexual dysfunctions.

Indexed as

AdultCohort StudiesCOVID-19Cross-Sectional StudiesErectile DysfunctionFemaleHumansMaleRetrospective StudiescoronavirusCOVID-19endothelial dysfunctionerectile dysfunctionSARS-CoV-2testosterone

Identifiers

PMID33742540
PMCPMC8250520
OpenAlexW3138083947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.